Unknown PHASE3 INTERVENTIONAL 2-arm NCT03374514

Cochlear Electrical Impedance and the Effect of Topical Dexamethasone on Cochlear Implant Surgery

Clinical Trial on Cochlear Electrical Impedance and the Effect of Topical Dexamethasone on Cochlear Implant Surgery: The Cochlea as a Capacitor

Sponsor: Hospital Italiano de Buenos Aires

Conditions Cochlear Implant Sensorineural Hearing Loss

Interventions Dexamethasone Sterile isotonic saline solution

Updated 7 times since 2017 Last updated: Dec 27, 2017 Started: Aug 9, 2017 Primary completion: Aug 31, 2018 Completion: Nov 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Cochlear Implant and Sensorineural Hearing Loss and is currently ongoing. Hospital Italiano de Buenos Aires leads this study, which shows 7 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE3
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jan 2020 — Jan 2021 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — Jan 2020 [monthly]

Recruiting PHASE3
Dec 2017 — Jun 2018 [monthly]

Recruiting PHASE3

First recorded

Aug 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Italiano de Buenos Aires

Data source: Hospital Italiano de Buenos Aires

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• CABA, Argentina